Background: Neurosteroids modulate epileptic activity by interacting with the γ-aminobutyric acid type A receptor, but their brain levels are still undetermined. Objectives: We aimed to establish neurosteroid levels in the neocortex and hippocampus by liquid chromatography/mass spectrometry in epileptic rats. Methods: Kainic acid-treated rats were continuously monitored up to 9 weeks to determine seizure frequency by video electrocorticography (n = 23) and compared to age-matched controls monitored in the same manner (n = 11). Results: Decreased allopregnanolone (–50%; p < 0.05, Mann-Whitney test) and pregnanolone levels (–64%; p < 0.01) were found in the hippocampus, whereas pregnenolone sulfate, pregnenolone, progesterone, and 5α-dihydroprogesterone were nonsignificantly reduced. No changes were found in the neocortex. Moreover, allopregnanolone (but not pregnanolone) levels were positively correlated with seizure frequency (r2 = 0.4606, p < 0.01). Conclusion: These findings indicate a selective reduction in hippocampal levels of 3α-reduced neurosteroids. This reduction was partially mitigated by seizures in the case of allopregnanolone.

1.
Weiss
SA
,
Staba
R
,
Bragin
A
,
Moxon
K
,
Sperling
M
,
Avoli
M
, et al.
“Interneurons and principal cell firing in human limbic areas at focal seizure onset”
.
Neurobiol Dis
.
2019
Apr
;
124
:
183
8
.
[PubMed]
0969-9961
2.
Belelli
D
,
Lambert
JJ
.
Neurosteroids: endogenous regulators of the GABA(A) receptor
.
Nat Rev Neurosci
.
2005
Jul
;
6
(
7
):
565
75
.
[PubMed]
1471-003X
3.
Reddy
DS
,
Rogawski
MA
. Neurosteroids – Endogenous Regulators of Seizure Susceptibility and Role in the Treatment of Epilepsy. In:
Noebels
JL
,
Avoli
M
,
Rogawski
MA
,
Olsen
RW
,
Delgado–Escueta
AV
, editors
.
Jasper’s basic mechanisms of the epilepsies
.
New York
:
Oxford University Press
;
2012
. pp.
984
1002
.
4.
Meletti
S
,
Lucchi
C
,
Monti
G
,
Giovannini
G
,
Bedin
R
,
Trenti
T
, et al.
Low levels of progesterone and derivatives in cerebrospinal fluid of patients affected by status epilepticus
.
J Neurochem
.
2018
Oct
;
147
(
2
):
275
84
.
[PubMed]
0022-3042
5.
Herzog
AG
,
Frye
CA
.
Seizure exacerbation associated with inhibition of progesterone metabolism
.
Ann Neurol
.
2003
Mar
;
53
(
3
):
390
1
.
[PubMed]
0364-5134
6.
Pugnaghi
M
,
Monti
G
,
Biagini
G
,
Meletti
S
.
Temporal lobe epilepsy exacerbation during pharmacological inhibition of endogenous neurosteroid synthesis
.
BMJ Case Rep
.
2013
Feb
;
2013
feb19 1
:
bcr2012008204
.
[PubMed]
1757-790X
7.
Lawrence
C
,
Martin
BS
,
Sun
C
,
Williamson
J
,
Kapur
J
.
Endogenous neurosteroid synthesis modulates seizure frequency
.
Ann Neurol
.
2010
May
;
67
(
5
):
689
93
.
[PubMed]
1531-8249
8.
Biagini
G
,
Longo
D
,
Baldelli
E
,
Zoli
M
,
Rogawski
MA
,
Bertazzoni
G
, et al.
Neurosteroids and epileptogenesis in the pilocarpine model: evidence for a relationship between P450scc induction and length of the latent period
.
Epilepsia
.
2009
Jan
;
50
Suppl 1
:
53
8
.
[PubMed]
0013-9580
9.
Joshi
S
,
Rajasekaran
K
,
Williamson
J
,
Kapur
J
.
Neurosteroid-sensitive δ-GABAA receptors: A role in epileptogenesis?
Epilepsia
.
2017
Mar
;
58
(
3
):
494
504
.
[PubMed]
0013-9580
10.
Costa
AM
,
Lucchi
C
,
Simonini
C
,
Rosal Lustosa
Í
,
Biagini
G
.
Status epilepticus dynamics predicts latency to spontaneous seizures in the kainic acid model
.
Cell Physiol Biochem
.
2020
May
;
54
(
3
):
493
507
.
[PubMed]
1015-8987
11.
Biagini
G
,
Pich
EM
.
Corticosterone administration to rat pups, but not maternal separation, affects sexual maturation and glucocorticoid receptor immunoreactivity in the testis
.
Pharmacol Biochem Behav
.
2002
Aug
;
73
(
1
):
95
103
.
[PubMed]
0091-3057
12.
Lévesque
M
,
Avoli
M
.
The kainic acid model of temporal lobe epilepsy
.
Neurosci Biobehav Rev
.
2013
Dec
;
37
(
10 Pt 2
):
2887
99
.
[PubMed]
0149-7634
13.
Mellon
SH
,
Griffin
LD
.
Neurosteroids: biochemistry and clinical significance
.
Trends Endocrinol Metab
.
2002
Jan-Feb
;
13
(
1
):
35
43
.
[PubMed]
1043-2760
14.
Miller
PS
,
Scott
S
,
Masiulis
S
,
De Colibus
L
,
Pardon
E
,
Steyaert
J
, et al.
Structural basis for GABAA receptor potentiation by neurosteroids
.
Nat Struct Mol Biol
.
2017
Nov
;
24
(
11
):
986
92
.
[PubMed]
1545-9993
15.
Norberg
L
,
Bäckström
T
,
Wahlström
G
.
Anaesthetic effects of pregnanolone in combination with allopregnanolone, thiopental, hexobarbital and flurazepam: an EEG study in the rat
.
Br J Anaesth
.
1999
May
;
82
(
5
):
731
7
.
[PubMed]
0007-0912
16.
Biagini
G
,
Marinelli
C
,
Panuccio
G
,
Puia
G
,
Avoli
M
. Glia-neuron interactions: Neurosteroids and epileptogenesis. In:
Noebels
JL
,
Avoli
M
,
Rogawski
M
,
Olsen
R
,
Delgado-Escueta
AV
, editors
.
Jasper’s Basic Mechanisms of the Epilepsies
.
Contemporary Neurology Series
.
Volume 80
. 4th ed.
New York
:
Oxford University Press
;
2012
. pp.
635
47
.
17.
Agís-Balboa
RC
,
Pinna
G
,
Zhubi
A
,
Maloku
E
,
Veldic
M
,
Costa
E
, et al.
Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis
.
Proc Natl Acad Sci USA
.
2006
Sep
;
103
(
39
):
14602
7
.
[PubMed]
0027-8424
18.
Schüle
C
,
Nothdurfter
C
,
Rupprecht
R
.
The role of allopregnanolone in depression and anxiety
.
Prog Neurobiol
.
2014
Feb
;
113
:
79
87
.
[PubMed]
0301-0082
19.
Nogueira
MH
,
Yasuda
CL
,
Coan
AC
,
Kanner
AM
,
Cendes
F
.
Concurrent mood and anxiety disorders are associated with pharmacoresistant seizures in patients with MTLE
.
Epilepsia
.
2017
Jul
;
58
(
7
):
1268
76
.
[PubMed]
0013-9580
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.